がん治療薬の世界市場 - 市場規模、シェア、成長分析：用途別（血液がん、肺がん）、治療法別（化学療法、標的療法） - 業界予測（2023年～2030年）

がん治療薬の世界市場規模は、2021年に1,665億米ドルとなりました。同市場は、2022年の1,816億5,000万米ドルから2030年には3,646億2,000万米ドルに成長する見通しです、

世界のがん治療薬市場は、ヘルスケア産業の中でもダイナミックで急速に発展している分野です。この市場には、化学療法、免疫療法、標的療法、放射線療法など、さまざまな種類のがんに対処するための幅広い治療法が含まれます。世界のがん罹患率の増加に伴い、この市場は絶え間ない研究開発努力、革新的な新薬の発見、精密医療の進歩によって特徴付けられています。この市場の主要参入企業には、製薬会社、バイオテクノロジー企業、研究機関などが含まれ、いずれも現在進行中のがんとの闘いにおいて、より良い治療選択肢を提供し、患者の転帰を改善しようと努力しています。

世界のがん罹患率の上昇は、がん治療薬市場成長の重要な促進要因です。高齢化、ライフスタイルの変化、環境暴露などの要因が、さまざまな種類のがんの有病率の上昇に寄与しており、効果的な治療オプションに対する需要の高まりを生み出しています。

ゲノミクス、プロテオミクス、分子診断学の技術的進歩により、がん生物学に対する理解が深まっています。こうした知識は、標的療法や個別化医療の開発につながり、治療成績の向上や副作用の軽減につながっています。

多くのがん治療、特に標的療法や免疫療法は高額です。高額な治療費は、低所得地域の患者のアクセスを制限し、個人にとってもヘルスケアシステムにとっても経済的負担の一因となります。

がん治療は副作用の軽減において大きな進歩を遂げていますが、化学療法など一部の治療法は依然として副作用や毒性を引き起こす可能性があります。重篤な副作用の可能性は、治療中の患者のコンプライアンスやQOLに影響を与える可能性があります。

がん治療に使用されるいくつかの生物製剤が特許切れとなったことで、バイオシミラーの開発と承認が増加しています。バイオシミラーは、高価ながん生物学的製剤に代わる費用対効果の高い代替品を提供し、患者の治療へのアクセスを向上させます。

当レポートは、世界のがん治療薬市場について調査し、市場の概要とともに、用途別、治療法別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

市場概要

親市場分析

市場概要

市場規模

• 市場力学
• 促進要因
• 機会
• 抑制要因
• 課題
• SWOT分析

主要な市場洞察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• 知財分析
• 貿易分析
• スタートアップ分析
• 原材料分析
• イノベーションマトリックス
• パイプライン製品の分析
• マクロ経済指標

新型コロナウイルスの影響

市場力学と見通し

• 市場力学
• 促進要因
• 機会
• 抑制要因
• 課題
• 規制状況
• SWOT分析
• ポーターズ分析

市場規模、地域別

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

主要企業プロファイル

• 競合情勢

Global Cancer Therapeutics Market size was valued at USD 166.5 Billion in 2021 and is poised to grow from USD 181.65 Billion in 2022 to USD 364.62 Billion by 2030,

The Global Cancer Therapeutics Market is a dynamic and rapidly evolving sector within the healthcare industry. It encompasses a wide range of treatments, including chemotherapy, immunotherapy, targeted therapies, and radiation therapy, aimed at combating various types of cancer. With increasing cancer incidence worldwide, the market is characterized by constant research and development efforts, innovative drug discoveries, and advancements in precision medicine. Key players in this market include pharmaceutical companies, biotechnology firms, and research institutions, all striving to provide better therapeutic options and improve patient outcomes in the ongoing battle against cancer.

Top-down and bottom-up approaches were used to estimate and validate the size of Cancer Therapeutics and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cancer Therapeutics Market Segmental Analysis Report

The global cancer therapeutics market is segmented on the basis of application, therapy, and region. By application, the market is segmented into blood cancer, lung cancer, and other types of cancer. By therapy, the market is segmented into chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and other treatment modalities. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Cancer Therapeutics Market Dynamics

Driver:

Rising Cancer Prevalence

The increasing incidence of cancer worldwide is a significant driver for the growth of the cancer therapeutics market. Factors such as an aging population, lifestyle changes, and environmental exposures contribute to the higher prevalence of various cancer types, creating a growing demand for effective treatment options.

Advancements in Medical Technology

Technological advancements in genomics, proteomics, and molecular diagnostics have enabled better understanding of cancer biology. This knowledge has led to the development of targeted therapies and personalised medicine, improving treatment outcomes and reducing side effects.

Restraint:

High Cost of Cancer Treatments

Many cancer therapies, especially targeted therapies and immunotherapies, are expensive. The high cost of treatment can limit access for patients in low-income regions and contribute to financial burden, both for individuals and healthcare systems.

Side Effects and Toxicity

While cancer therapies have made significant progress in reducing side effects, some treatments, such as chemotherapy, can still cause adverse reactions and toxicity. The potential for severe side effects may impact patient compliance and quality of life during treatment.

Global Cancer Therapeutics Key Market Trends

Development of Biosimilars: With several biologics used in cancer treatment coming off-patent, there has been an increase in the development and approval of biosimilars. Biosimilars offer cost-effective alternatives to expensive cancer biologics, increasing patient access to treatment.

Personalized Cancer Vaccines: The development of personalised cancer vaccines is a promising area of research. These vaccines are tailored to individual patients based on their tumour's genetic profile, potentially offering a more targeted and effective treatment approach.

Table of Contents

Executive Summary

Market overview

• Exhibit: Executive Summary - Chart on Market Overview
• Exhibit: Executive Summary - Data Table on Market Overview
• Exhibit: Executive Summary - Chart on Global Cancer Therapeutics Market Characteristics
• Exhibit: Executive Summary - Chart on Market by Geography
• Exhibit: Executive Summary - Chart on Market Segmentation
• Exhibit: Executive Summary - Chart on Incremental Growth
• Exhibit: Executive Summary - Data Table on Incremental Growth
• Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

• Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
• Drivers
• Opportunities
• Restraints
• Challenges
• SWOT Analysis

KEY MARKET INSIGHTS

• Technology Analysis
  • (Exhibit: Data Table: Name of technology and details)
• Pricing Analysis
  • (Exhibit: Data Table: Name of technology and pricing details)
• Supply Chain Analysis
  • (Exhibit: Detailed Supply Chain Presentation)
• Value Chain Analysis
  • (Exhibit: Detailed Value Chain Presentation)
• Ecosystem Of the Market
  • Exhibit: Parent Market Ecosystem Market Analysis
  • Exhibit: Market Characteristics of Parent Market
• IP Analysis
  • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
• Trade Analysis
  • (Exhibit: Data Table: Import and Export data details)
• Startup Analysis
  • (Exhibit: Data Table: Emerging startups details)
• Raw Material Analysis
  • (Exhibit: Data Table: Mapping of key raw materials)
• Innovation Matrix
  • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
• Pipeline product Analysis
  • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
• Macroeconomic Indicators

COVID IMPACT

• Introduction
• Impact On Economy-scenario Assessment
  • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
• Revised Market Size
  • Exhibit: Data Table on Global Cancer Therapeutics Market size and forecast 2021-2027 ($ million)
• Impact Of COVID On Key Segments
  • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
• COVID Strategies By Company
  • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

• Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
• Drivers
• Opportunities
• Restraints
• Challenges
• Regulatory Landscape
  • Exhibit: Data Table on regulation from different region
• SWOT Analysis
• Porters Analysis
  • Competitive rivalry
• Exhibit: Competitive rivalry Impact of key factors, 2021
  • Threat of substitute products
• Exhibit: Threat of Substitute Products Impact of key factors, 2021
  • Bargaining power of buyers
• Exhibit: buyers bargaining power Impact of key factors, 2021
  • Threat of new entrants
• Exhibit: Threat of new entrants Impact of key factors, 2021
  • Bargaining power of suppliers
• Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
• Skyquest special insights on future disruptions
  • Political Impact
  • Economic impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Market Size by Region

• Chart on Market share by geography 2021-2027 (%)
• Data Table on Market share by geography 2021-2027(%)
• North America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • USA
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Canada
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
• Europe
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Germany
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Spain
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • France
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • UK
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Europe
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
• Asia Pacific
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • China
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • India
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Japan
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Korea
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Asia Pacific
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
• Latin America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Brazil
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of South America
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
• Middle East & Africa (MEA)
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • GCC Countries
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Africa
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of MEA
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

• Competitive Landscape
  • Total number of companies covered
• Exhibit: companies covered in the report, 2021
  • Top companies market positioning
• Exhibit: company positioning matrix, 2021
  • Top companies market Share
• Exhibit: Pie chart analysis on company market share, 2021(%)